One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
The Me Decade
-
Tom Wolfe once designated the 1970s as “The Me Decade”. It seems to me
that this label better applies to the 2020s. Consider *this action* by the
New Y...
8 hours ago
No comments:
Post a Comment